CSC
CELU icon

Caldwell Sutter Capital’s Celularity CELU Stock Holding History

Caldwell Sutter Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598 Hold
1,000
– – ﹤0.01% 884
2026
Q1 		$1.33K Hold
1,000
– – ﹤0.01% 792
2025
Q4 		$1.11K Hold
1,000
– – ﹤0.01% 798
2025
Q3 		$2.07K Buy
+1,000
New +$2.8K ﹤0.01% 738

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Caldwell Sutter Capital's CELU Position: Q2 2026 in Review

Caldwell Sutter Capital held its Celularity (CELU) position steady in Q2 2026 at 1,000 shares worth $598. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Caldwell Sutter Capital first reported a position in CELU in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.07K in Q3 2025. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Caldwell Sutter Capital held 1,000 shares of Celularity worth $598 as of Q2 2026.
  • Caldwell Sutter Capital left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #884 holding.
  • Caldwell Sutter Capital first reported a position in Celularity in Q3 2025 and has held it in 4 quarters since.
  • Caldwell Sutter Capital's Celularity position peaked at $2.07K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.